Skip to main content

Overview

Dr. Lisa Mosconi, PhD, is an associate professor of Neuroscience in Neurology at Weill Cornell Medical College (WCMC)/NewYork-Presbyterian Hospital, were she serves as Director of the Women's Brain Initiative, and Associate Director of the Alzheimer's Prevention Clinic. Formerly, Dr. Mosconi founded and was the director of the Nutrition & Brain Fitness Lab at New York University School of Medicine (NYU), and an assistant professor in the NYU Department of Psychiatry. Dr. Mosconi holds a PhD degree in Neuroscience and Nuclear Medicine from the University of Florence, Italy, and is a board certified integrative nutritionist and holistic healthcare practitioner. She is well known for her brain imaging research on the early detection of Alzheimer’s disease. Her work is focused on risk reduction and prevention of memory loss and dementia through medical interventions and lifestyle modifications including diet, nutrition, physical and intellectual fitness.

Highlights

  1. 1
    Scientific reports · 2024
    PMID: 38448497PMCID: PMC10918173DOIFirst author17 citations
  2. 2
    Scientific reports · 2022
    PMID: 36543814PMCID: PMC9772209DOISenior author26 citations
  3. 3
    Menopause (New York, N.Y.) · 2025
    PMID: 40067757DOIFirst author9 citations

Publications

138 publications

Active

4 grants
  • PI
    Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD
    NIA · 2026–2031 · via NIH RePORTER
    U01AG095263-01
  • Sub-PI
    PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
    National Institute on Aging · 2022–2027 · via University of Arizona
    R01AG075122-04
  • Sub-PI
    Perimenopause in Brain Aging and Alzheimer's disease
    National Institute on Aging · 2016–2026 · via University of Arizona· 3 renewals
    P01AG026572-19
  • KP
    New PET/CT System for Human and Non-human Primate Imaging
    Office of the Director, NIH · 2023–2026
    S10OD034271-01
Completed grants (12)
  • KP
    7T Magnetic Resonance Imaging System for Basic, Translational and Clinical Research
    Office of the Director, NIH · 2021–2025
    S10OD027039-01A1
  • Sub-PI
    Sex Differences in the Molecular Determinants of Alzheimer’s Disease Risk
    National Institute on Aging · 2018–2024 · via University of Arizona· 2 renewals
    R01AG057931-05
  • Sub-PI
    Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's
    National Institute on Aging · 2018–2024 · via New York University
    R01AG055624-05
  • KP
    Major Cyclotron Upgrades and Refurbishment
    Office of the Director, NIH · 2021–2023
    S10OD030447-01
  • MPI
    Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1
    CTSC Cost Share · 2017–2022
    CTSC Internal Funding UL1
  • Sub-PI
    Neuroenergetic Adaptations in Alzheimer's Disease: Implications on Amyloid Burden and Cognition
    National Institute on Aging · 2019–2022 · via New York University School of Medicine (Grossman)
    R21AG061579-02
  • PI
    ADMdx Statement of Work
    ADM Diagnostics, Inc. (ADMdx) · 2020–2022Contract
    SA 202163-01
  • PI
    Alzheimer’s risk is higher in women: identification of female-specific bioenergetic targets
    Cure Alzheimer’s Fund · 2018–2021
    CAF 183574-02
  • Co-I
    Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's Disease
    National Institute on Aging · 2019–2021
    R56AG064873-01
  • MPI
    History of Alzheimer predisposes children to amyloid beta-related hypometabolism
    NIA · 2010–2017 · via NIH RePORTER
    R01AG035137-05
  • PI
    PRECLINICAL DETECTION OF AD (ABBREAVIATE AS FAMHXAD)
    NCRR · 2011–2012 · via NIH RePORTER
    P41RR013642-14
  • PI
    Family History of Alzheimer's, Hypometabolism and Oxidative Stress
    NIA · 2008–2011 · via NIH RePORTER
    R21AG032554-02

Clinical research

1 study

Active

1 study
  • PI
    PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
    PHASE2 · University of Arizona · OPEN TO ACCRUAL (as of 2023)
    Menopause; Cognitive Change; Brain Disorder, Metabolic
    NCT05664477

News mentions

  • Scans Show Brain's Estrogen Activity Changes During Menopause
    June 20, 2024

    The transition to menopause is marked by a progressively higher density of estrogen receptors (ER) on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study led by researchers at Weill Cornell Medicine.

  • Study Suggests Estrogen to Prevent Alzheimer’s Warrants Renewed Research Interest
    October 23, 2023

    Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.

  • For Women, Greater Exposure to Estrogen in Life May Protect Brain Regions That Are Vulnerable to Alzheimer’s
    November 3, 2021

    The drop in estrogen levels that occurs with menopause brings declines in the volumes of “gray matter,” the cellular matter of the brain, in key brain regions that are also affected in Alzheimer’s disease. But a new study from Weill Cornell Medicine researchers, in collaboration with the University of Arizona, suggests that greater cumulative exposure to estrogen in life

  • Imaging Study Reveals Brain Changes During the Transition to Menopause
    June 9, 2021

    The transition from pre- to post-menopause, with its steep decline in estrogen production, involves myriad changes to brain structure, brain-region connectivity, and brain energy consumption, though many of these changes are only temporary, a study led by researchers at Weill Cornell Medicine has found.

  • Gender Disparity
    April 10, 2019

    Neuroscientist Dr. Lisa Mosconi explores why women have a much higher risk of Alzheimer’s disease than men.

Media highlights

3 clips